글로벌 말더듬 방지 장치 시장 – 2023-2030

Global Stuttering Devices Market - 2023-2030

상품코드MD7391
발행기관DataM Intelligence
발행일2023.11.01
페이지 수187 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

개요
전 세계 말더듬 치료 기기 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
말더듬은 유창성 장애, 더듬거림 또는 아동기 발병 유창성 장애라고도 합니다. 이는 정상적인 말의 유창성과 흐름에 빈번하고 심각한 문제가 발생하는 언어 장애입니다. 말더듬이 있는 사람은 말하고자 하는 바는 알지만, 그것을 표현하는 데 어려움을 겪습니다. 이로 인해 말의 흐름이 끊기고, 의도치 않은 소리나 멈춤, 단어 끝맺음 등이 발생합니다. 이 증상은 주로 아동에게 나타나지만, 모든 연령대에서 발생할 수 있습니다. 말더듬은 치료 가능한 질환입니다.
또한, 전자식 유창성 보조 기기, 의사소통 기기, 음성 생성 기기, 보청기 및 말더듬 방지 기기는 말더듬 증상 개선을 위해 일반적으로 사용됩니다. 전자식 유창성 보조 장치(보조 기기, 전자 보조 장치, 변형 청각 및 피드백 장치라고도 함)는 말더듬 환자의 유창성을 향상시키기 위해 고안된 전자 장치입니다. 대부분의 전자식 유창성 보조 장치는 환자의 귀에 들리는 사용자 목소리의 음량을 변형합니다. 의사소통 장치 및 음성 생성 장치는 언어적 의사소통을 용이하게 하고 효율성을 높이는 데 도움을 줍니다.
시장 동향: 성장 동력
첨단 기술의 기기 채택 증가
첨단 기술의 기기 채택이 증가함에 따라 예측 기간 동안 시장 성장이 촉진될 것으로 예상됩니다. 인공지능(AI), 가상 현실(VR), 웨어러블 기기를 포함한 기술의 지속적인 발전은 고급스럽고 편안한 기능을 갖춘 말더듬 치료를 위한 새롭고 혁신적인 솔루션을 제공합니다. 이러한 기술은 개인 맞춤형 연습과 몰입형 경험을 제공하여 이러한 첨단 기기를 활용한 언어 치료의 효과를 향상시킬 수 있습니다.
예를 들어, AONDevices는 2023년 6월 8일, 최소한의 전력과 지연 시간을 요구하는 애플리케이션을 위해 설계된 소형 고효율 엣지 AI 노이즈 제거 기술인 AONDenoise를 출시했습니다. AONDenoise는 5만 개의 파라미터를 가지고 있어 가장 작은 노이즈 제거 알고리즘 중 하나이며, 보청기, 무선 이어폰 및 웨어러블 기기에 사용하기에 이상적인 AI 음성 향상 도구입니다.
또한, 고급 기기는 사용자 친화적인 인터페이스를 제공하여 언어 치료를 받는 사람들이 쉽게 접근하고 사용할 수 있도록 합니다. 향상된 사용자 경험은 이러한 기기의 사용률을 높이는 데 기여할 수 있습니다. 고급 기기는 인공지능을 사용하여 개인의 음성 패턴을 분석하고 맞춤형 치료 계획을 수립할 수 있습니다. 개인 맞춤형 치료 접근 방식은 말더듬으로 고통받는 각 개인의 고유한 요구 사항을 해결하는 데 더 효과적인 경우가 많습니다.
더불어, 보완 및 대체 의사소통(AAC) 장치와 같은 의사소통 장치의 발전은 언어 치료에서 이러한 장치의 사용률을 향상시킬 가능성이 높습니다. 기술적으로 발전된 말더듬 장치의 효능에 대한 연구가 더 많이 진행됨에 따라 의료 전문가들은 이러한 장치를 치료 계획에 통합하는 것에 대해 더 잘 알게 될 것입니다.
예를 들어, 2020년 9월 1일, Control Bionics는 보완 및 대체 의사소통(AAC) 장치 라인에 최신 제품인 GridPad Trilogy 의사소통 솔루션을 출시했습니다. GridPad Trilogy는 터치 제어, 시선 제어, NeuroNode 3.0 제어 기능을 하나의 시스템 내에서 제공하는 독특한 3-in-1 AAC 장치로, 사용자의 능력과 함께 발전하고 성장합니다. 다른 시스템보다 최대 133% 빠른 속도로 의사소통을 가능하게 합니다.
또한, 특히 아동에게서 말더듬이 증가하는 추세, 보다 적합한 장치 개발을 위한 임상 시험 증가, 언어 치료 장치에 대한 인식 제고, 그리고 새로운 장치 개발의 발전은 예측 기간 동안 시장 성장을 견인할 것으로 예상되는 요인입니다.
제한 요인
말더듬 치료 장치 사용과 관련된 합병증 및 위험, 높은 장치 가격, 그리고 배경 소음이 심한 환경에서 자주 말할 때 장치의 효과가 떨어지는 점 등이 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
전 세계 말더듬 치료 장치 시장은 질병 유형, 장치 유형, 최종 사용자 및 지역별로 세분화됩니다.

전자식 유창성 향상 장치 부문은 염증성 근염 치료 시장 점유율의 약 37.8%를 차지했습니다.
전자식 유창성 향상 장치 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 많은 전자식 유창성 향상 장치는 말더듬이 있는 사람들에게 실시간 청각 피드백을 제공하는 것으로 알려져 있습니다. 이러한 피드백에는 개인의 음성을 변형하여 실시간으로 재생하는 변형된 청각 피드백이 포함될 수 있습니다. 이 과정을 통해 개인은 자신의 발화 패턴을 더 잘 인식하고 말더듬을 방지하여 유창성을 향상시키기 위해 의식적인 조정을 할 수 있습니다.
또한, 많은 전자식 유창성 향상 장치는 휴대 가능하고 눈에 띄지 않도록 설계되었습니다. 따라서 개인은 큰 주목을 받지 않고 일상생활에 이러한 장치를 통합하여 사용할 수 있습니다. 휴대용 장치는 특히 다양한 환경에서 유창성 기법을 연습하려는 사람들에게 편리합니다. 이러한 장치는 환자의 필요에 따라 가정 간호 환경에서 사용할 수 있습니다.
더 나아가, 이러한 전자식 유창성 향상 장치는 음성을 지연시키거나 변형하여 메아리를 만들거나 특정 소음을 재생하는 등의 방법을 사용하는데, 이러한 방법들은 모두 말더듬을 줄이는 데 효과적인 것으로 알려져 있습니다. 하지만 시간이 지남에 따라 효과가 감소할 수 있다는 점도 알려져 있습니다.
지리적 분석
북미는 시장 점유율의 약 40.1%를 차지했습니다.
북미 지역은 주요 업체들의 강력한 입지와 기기 채택 증가로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 특히 미국을 중심으로 생명공학 기업과 의료기기 회사와 같은 주요 업체들이 첨단 기기 개발에 주력하고 있습니다. 이러한 주요 업체들은 말더듬 치료 기기 개발에 적극적으로 참여하고 있습니다.
예를 들어, 수상 경력에 빛나는 디지털 치료 제공업체인 러닝 코프(Learning Corp)는 2020년 4월 14일, 뇌졸중 환자에게 접근성 높은 인지, 언어 및 발음 치료를 제공하도록 설계된 음성 치료 기기에 대해 미국 식품의약국(FDA)으로부터 혁신 의료기기(Breakthrough Device) 지정을 받았다고 발표했습니다.
또한, 이 지역에서 말더듬 사례가 증가함에 따라 언어 치료 분야에서 말더듬 치료 기기의 채택이 증가할 것으로 예상됩니다. 예를 들어, 미국 말더듬 재단(Stuttering Foundation of America)에 따르면 미국에는 300만 명의 사람들이 말더듬으로 고통받고 있습니다. 이러한 증가 추세는 말더듬 치료 기기에 대한 수요 증가로 이어지고 있습니다.
경쟁 환경
말더듬 치료 기기 시장의 주요 글로벌 업체로는 Takalam Tech, Casa Futura Technologies, SpeechEasy, Tobii Dynavox AB, PRC-Saltillo, DrSpectra, Attainment Company, Inc., Lingraphica, Numotion, AbleNet, Inc. 등이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 말더듬 치료 기기 시장에 상당한 영향을 미쳤습니다. 팬데믹으로 인해 글로벌 공급망이 차질을 빚으면서 말더듬 치료 기기의 생산 및 유통에 차질이 발생했습니다. 또한 팬데믹은 원격 의료 서비스의 도입을 가속화했습니다. 이러한 변화는 원격 의료 상담을 용이하게 했지만, 가상 세션에서 효과적으로 활용될 수 있는 치료 유형과 기기에도 영향을 미쳐 특정 말더듬 치료 기기의 사용에 잠재적인 영향을 미칠 수 있습니다.

시장 세분화
질병 유형별
• 발달성 말더듬(아동기 발병 유창성 장애)
• 지속성 말더듬
• 후천성 말더듬
o 신경성 말더듬
o 심인성 말더듬
기기 유형별
• 전자식 유창성 보조 기기
• 의사소통 기기
• 음성 생성 기기
• 보청기
• 기타
최종 사용자별
• 병원
• 전문 클리닉
• 언어 치료 센터
• 가정 간호 환경
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
보고서 구매 이유

• 질병 유형, 기기 유형, 최종 사용자 및 지역별 글로벌 말더듬 치료 기기 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.
• 모든 세그먼트를 포함한 말더듬 치료 기기 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 Excel 파일로 제공합니다.

글로벌 말더듬 치료 기기 시장 보고서는 약 61개의 표, 61개의 그림, 187페이지 분량입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global stuttering devices market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
Stuttering is also known as disfluency, stammering or childhood-onset fluency disorder. It is a speech disorder that involves frequent and significant problems with normal fluency and flow of speech. People who stutter know what they want to say, but have difficulty saying it. This disrupts the flow of speech and causes pauses, unintended sounds and sticking on words. This condition usually affects children but can have impacts at any age. It’s a treatable condition.
Moreover, electronic fluency devices, communication devices, speech-generating devices, hearing aids and anti-stammering devices are commonly used in stuttering to improve speech fluency. Electronic fluency devices also known as assistive devices, electronic aids, altered auditory and feedback devices are electronic devices intended to improve fluency for stuttering patients. Most electronic fluency devices change the sound of the user's voice in the patient's ear. Communication devices and speech-generating devices helps to verbally communicate with ease and increase efficiency.
Market Dynamics: Drivers
Increasing adoption of technologically advanced devices
The increasing adoption of technologically advanced devices are expected to drive the market over the forecast period. Continuous advancements in technology, including artificial intelligence (AI), virtual reality (VR), and wearable devices, offer new and innovative solutions for stuttering therapy with advanced and comfortable features. These technologies can provide personalized exercises and immersive experiences, enhancing the effectiveness of speech therapy by using these advanced devices.
For instance, on June 08, 2023, AONDevices launched its AONDenoise, a compact, efficient edge AI denoising technology designed for applications that require minimal power and latency. AONDenoise has 50K parameters, making it one of the smallest denoising algorithms available, and ideal AI speech enhancement for use in hearing aids, wireless earbuds and wearables.
Moreover, advanced devices often come with user-friendly interfaces, making them accessible and easy to use for individuals seeking speech therapy. The improved user experience can contribute to higher adoption of these devices. Advanced devices can use artificial intelligence to analyze individual speech patterns and customize treatment plans. Personalized therapy approaches are often more effective in addressing the unique needs of each person who are suffering from stuttering.
In Addition, the advancements in communication devices like augmentative and alternative communication devices are most likely to improve the adoption of the devices in speech therapy. As more research is conducted on the efficacy of technologically advanced stuttering devices, healthcare professionals may be more aware of integrating these devices into their treatment plans.
For instance, on September 1, 2020, Control Bionics released the newest addition to its Augmentative and Alternative Communication (AAC) device line, the GridPad Trilogy communication solution. Offering touch control, eye control, and NeuroNode 3.0 control within the same system, the GridPad Trilogy is a unique 3-in-1 AAC device that progresses and grows with clients and their abilities. It allows for faster communication, at rates up to 133 percent that of other systems.
Further, the increasing prevalence of stuttering mostly in children, increasing clinical trials to develop more appropriate devices, increasing awareness about the speech therapy devices and advancements in the development of novel devices are the factors expected to drive the market over the forecast period.
Restraints
Factors such as complications and risks associated with the use of stuttering devices, the high cost of the devices and these devices also do not work well when the person is frequently speaking in environments with significant background noise are expected to hamper the market.
Segment Analysis
The global stuttering devices market is segmented based on disease type, device type, end-user and region.
The electronic fluency devices segment accounted for approximately 37.8% of the inflammatory myositis treatment market share
The electronic fluency devices segment is expected to hold the largest market share over the forecast period. Many electronic fluency devices are known to provide real-time auditory feedback to individuals who are suffering from stuttering. This feedback can include altered auditory feedback, which involves modifying the individual's own speech and playing it back in real-time. This process can help individuals become more aware of their speech patterns and make conscious adjustments to improve fluency by avoiding the stuttering.
Additionally, many electronic fluency devices are designed to be portable and discreet. This allows individuals to incorporate the use of these devices into their daily lives without drawing significant attention. Portable devices are particularly convenient for those who want to practice fluency techniques in various settings. These devices can be used in homecare settings according to the patient's priority.
Moreover, these electronic fluency devices either delay or alter the sound of one's voice, creating an echo, or playing some sort of noise, both of which are known to reduce stuttering. However, it is also known that the effects may wear off over time.
Geographical Analysis
North America accounted for approximately 40.1% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of the devices. North America especially the United States is known for its strong presence of major players such as biotechnology companies and medical device companies which are focussing on the development of the more advanced devices. The presence of major players actively focussing on developing the devices for stuttering.
For instance, on April 14, 2020, the Learning Corp, an award-winning digital therapeutics provider, cleared that it had received Breakthrough Device designation from the United States Food and Drug Administration (FDA) for its Speech Therapy, which is designed to provide accessible cognitive, speech and language therapy to stroke patients.
Moreover, the increasing prevalence of stuttering cases in the region is expected to increase the adoption of stuttering devices in speech therapy. For instance, according to the Stuttering Foundation of America, There are 3 million people in the United States suffering from stuttering. This increasing prevalence is increasing the demand for stuttering devices.
Competitive Landscape
The major global players in the stuttering devices market include Takalam Tech, Casa Futura Technologies, SpeechEasy, Tobii Dynavox AB, PRC-Saltillo, DrSpectra, Attainment Company, Inc., Lingraphica, Numotion and AbleNet, Inc. among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global stuttering devices market. The pandemic led to disruptions in global supply chains, affecting the production and distribution of stuttering devices. The pandemic accelerated the adoption of telehealth services. While this shift facilitated the remote healthcare consultations, it also influenced the types of interventions and devices that could be effectively utilized during virtual sessions, potentially impacting the use of certain stuttering devices.
Market Segmentation
By Disease Type
• Developmental Stuttering (Child-Onset Fluency Disorder)
• Persistent Stuttering
• Acquired Stuttering
o Neurogenic Stuttering
o Psychogenic Stuttering
By Device Type
• Electronic Fluency Devices
• Communication Devices
• Speech Generating Devices
• Hearing Aids
• Others
By End-User
• Hospitals
• Specialty Clinics
• Speech Therapy Centers
• Homecare Settings
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global stuttering devices market segmentation based on disease type, device type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of stuttering devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global stuttering devices market report would provide approximately 61 tables, 61 figures, and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Disease Type
3.2. Snippet by Device Type
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption of Stuttering Devices
4.1.2. Restraints
4.1.2.1. Complications and Risks Associated with the Devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Disease Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
7.1.2. Market Attractiveness Index, By Disease Type
7.2. Developmental Stuttering (Child-Onset Fluency Disorder) *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Persistent Stuttering
7.4. Acquired Stuttering
7.4.1. Neurogenic Stuttering
7.4.2. Psychogenic Stuttering
8. By Device Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
8.1.2. Market Attractiveness Index, By Device Type
8.2. Electronic Fluency Devices*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Communication Devices
8.4. Speech Generating Devices
8.5. Hearing Aids
8.6. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Speech Therapy Centers
9.5. Homecare Settings
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Takalam Tech*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Casa Futura Technologies
12.3. SpeechEasy
12.4. Tobii Dynavox AB
12.5. PRC-Saltillo
12.6. DrSpectra
12.7. Attainment Company, Inc.
12.8. Lingraphica
12.9. Numotion
12.10. AbleNet, Inc.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Takalam Tech, 4. Key Developments, Casa Futura Technologies, SpeechEasy, Tobii Dynavox AB, PRC-Saltillo, DrSpectra, Attainment Company, Inc., Lingraphica, Numotion, AbleNet, Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Stuttering Devices Market Value, By Disease Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Stuttering Devices Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Stuttering Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Stuttering Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Stuttering Devices Market Value, By Disease Type, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Stuttering Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 7 Global Stuttering Devices Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 8 Global Stuttering Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 9 Global Stuttering Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 10 Global Stuttering Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 11 Global Stuttering Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 12 Global Stuttering Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 13 North America Stuttering Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 14 North America Stuttering Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 15 North America Stuttering Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 16 North America Stuttering Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 17 South America Stuttering Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 18 South America Stuttering Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 19 South America Stuttering Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 20 South America Stuttering Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 21 Europe Stuttering Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 22 Europe Stuttering Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 23 Europe Stuttering Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 24 Europe Stuttering Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 25 Asia-Pacific Stuttering Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 26 Asia-Pacific Stuttering Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 27 Asia-Pacific Stuttering Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 28 Asia-Pacific Stuttering Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 29 Middle East & Africa Stuttering Devices Market Value, By Disease Type, 2021-2030 (US$ Million)

Table 30 Middle East & Africa Stuttering Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 31 Middle East & Africa Stuttering Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 32 Takalam Tech: Overview

Table 33 Takalam Tech: Product Portfolio

Table 34 Takalam Tech: Key Developments

Table 35 Casa Futura Technologies: Overview

Table 36 Casa Futura Technologies: Product Portfolio

Table 37 Casa Futura Technologies: Key Developments

Table 38 SpeechEasy: Overview

Table 39 SpeechEasy: Product Portfolio

Table 40 SpeechEasy: Key Developments

Table 41 Tobii Dynavox AB: Overview

Table 42 Tobii Dynavox AB: Product Portfolio

Table 43 Tobii Dynavox AB: Key Developments

Table 44 PRC-Saltillo: Overview

Table 45 PRC-Saltillo: Product Portfolio

Table 46 PRC-Saltillo: Key Developments

Table 47 DrSpectra: Overview

Table 48 DrSpectra: Product Portfolio

Table 49 DrSpectra: Key Developments

Table 50 Attainment Company, Inc.: Overview

Table 51 Attainment Company, Inc.: Product Portfolio

Table 52 Attainment Company, Inc.: Key Developments

Table 53 Lingraphica: Overview

Table 54 Lingraphica: Product Portfolio

Table 55 Lingraphica: Key Developments

Table 56 Numotion: Overview

Table 57 Numotion: Product Portfolio

Table 58 Numotion: Key Developments

Table 59 AbleNet, Inc.: Overview

Table 60 AbleNet, Inc.: Product Portfolio

Table 61 AbleNet, Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Stuttering Devices Market Share, By Disease Type, 2022 & 2030 (%)

Figure 3 Global Stuttering Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 4 Global Stuttering Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 5 Global Stuttering Devices Market Share, By Region, 2022 & 2030 (%)

Figure 6 Global Stuttering Devices Market Y-o-Y Growth, By Disease Type, 2022-2030 (%)

Figure 7 Developmental Stuttering (Child-Onset Fluency Disorder) Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 8 Persistent Stuttering Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Acquired Stuttering Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Global Stuttering Devices Market Y-o-Y Growth, By Device Type, 2022-2030 (%)

Figure 11 Electronic Fluency Devices Device Type in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Communication Devices Device Type in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 13 Speech Generating Devices Device Type in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Hearing Aids Device Type in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Others Device Type in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Global Stuttering Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 17 Hospitals End-User in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 18 Specialty Clinics End-User in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Speech Therapy Centers End-User in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Homecare Settings End-User in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 21 Others End-User in Global Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 22 Global Stuttering Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 26 South America Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 28 North America Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 29 North America Stuttering Devices Market Share, By Disease Type, 2022 & 2030 (%)

Figure 30 North America Stuttering Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 31 North America Stuttering Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 32 North America Stuttering Devices Market Share, By Country, 2022 & 2030 (%)

Figure 33 South America Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 34 South America Stuttering Devices Market Share, By Disease Type, 2022 & 2030 (%)

Figure 35 South America Stuttering Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 36 South America Stuttering Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 37 South America Stuttering Devices Market Share, By Country, 2022 & 2030 (%)

Figure 38 Europe Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 39 Europe Stuttering Devices Market Share, By Disease Type, 2022 & 2030 (%)

Figure 40 Europe Stuttering Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 41 Europe Stuttering Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 42 Europe Stuttering Devices Market Share, By Country, 2022 & 2030 (%)

Figure 43 Asia-Pacific Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 44 Asia-Pacific Stuttering Devices Market Share, By Disease Type, 2022 & 2030 (%)

Figure 45 Asia-Pacific Stuttering Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 46 Asia-Pacific Stuttering Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 47 Asia-Pacific Stuttering Devices Market Share, By Country, 2022 & 2030 (%)

Figure 48 Middle East & Africa Stuttering Devices Market Value, 2021-2030 (US$ Million)

Figure 49 Middle East & Africa Stuttering Devices Market Share, By Disease Type, 2022 & 2030 (%)

Figure 50 Middle East & Africa Stuttering Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 51 Middle East & Africa Stuttering Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 52 Takalam Tech: Financials

Figure 53 Casa Futura Technologies: Financials

Figure 54 SpeechEasy: Financials

Figure 55 Tobii Dynavox AB: Financials

Figure 56 PRC-Saltillo: Financials

Figure 57 DrSpectra: Financials

Figure 58 Attainment Company, Inc.: Financials

Figure 59 Lingraphica: Financials

Figure 60 Numotion: Financials

Figure 61 AbleNet, Inc.: Financials